4//SEC Filing
Albright Charles 4
Accession 0001179110-20-010963
CIK 0001650664other
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 4:13 PM ET
Size
4.8 KB
Accession
0001179110-20-010963
Insider Transaction Report
Form 4
Albright Charles
Chief Scientific Officer
Transactions
- Sale
Common Stock
2020-11-09$31.21/sh−228$7,116→ 24,907 total
Footnotes (1)
- [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on May 11, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on November 6, 2020. The sale does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
Related Parties
1- filerCIK 0001682323
Filing Metadata
- Form type
- 4
- Filed
- Nov 9, 7:00 PM ET
- Accepted
- Nov 10, 4:13 PM ET
- Size
- 4.8 KB